Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors

Clinical trial NCT06902350 · RECRUITING

Trial details

NCT number: NCT06902350
Sponsor: Chipscreen Biosciences, Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Glioblastoma, Adult Small Cell Lung Carcinoma (SCLC)

Start date: 2025-05-21
Primary completion: 2029-04-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.